Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy

Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and molecular imaging (MI), including positron emission tomography (PET), single-photon emission computed tomography (SPECT) and planar scintigraphy, for patient diagnosis, therapy, and personalized management. While the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Barca, Cristina, Griessinger, Christoph M., Faust, Andreas, Depke, Dominic, Essler, Markus, Windhorst, Albert D., Devoogdt, Nick, Brindle, Kevin M., Schäfers, Michael, Zinnhardt, Bastian, Jacobs, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780589/
https://www.ncbi.nlm.nih.gov/pubmed/35056071
http://dx.doi.org/10.3390/ph15010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780589/
https://www.ncbi.nlm.nih.gov/pubmed/35056071
http://dx.doi.org/10.3390/ph15010013

Ejemplares similares